The landscape of clinical trials, a critical yet notoriously complex phase in drug development, is on the cusp of a…
Read More
TWiV 1284: Clinical update with Dr. Daniel Griffin
In a timely post-New Year’s Day discussion, This Week in Virology (TWiV) episode 1284 features Dr. Daniel Griffin, a practicing…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin Addresses Alarming Shifts in Public Health Discourse and Data
In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin, alongside host Vincent Racaniello, expressed profound bewilderment…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, expressed profound bewilderment and dismay regarding announced changes to…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies
In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive overview…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
The recent weekly clinical update on "This Week in Virology" (TWiV) podcast, hosted by Vincent Racaniello and featuring Dr. Daniel…
Read More
A Coordinated Medical Approach for Cardiovascular-Kidney-Metabolic Syndrome: A New Clinical Guideline
A landmark clinical guideline, published on June 9th in the esteemed journal Circulation, heralds a significant paradigm shift in the…
Read More
A Coordinated Medical Approach to Overlapping Cardiovascular, Kidney, and Metabolic Conditions Emerges in New Clinical Guideline
A groundbreaking clinical guideline published on June 9 in the esteemed journal Circulation heralds a significant shift in how prevalent…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
The latest clinical update from the popular "This Week in Virology" (TWiV) podcast, episode 1292, hosted by Vincent Racaniello and…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read MoreYOU MAY HAVE MISSED
